130 related articles for article (PubMed ID: 18064346)
1. Fondaparinux as an alternative therapy in heparin-induced delayed-type hypersensitivity skin lesions.
O'Meara AC; Demarmels Biasiutti F; Heizmann M
Thromb Haemost; 2007 Dec; 98(6):1389-91. PubMed ID: 18064346
[No Abstract] [Full Text] [Related]
2. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
[No Abstract] [Full Text] [Related]
3. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
Irion R; Gall H; Peter RU
Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
[No Abstract] [Full Text] [Related]
4. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy.
Maetzke J; Hinrichs R; Staib G; Scharffetter-Kochanek K
Allergy; 2004 Feb; 59(2):237-8. PubMed ID: 14763948
[No Abstract] [Full Text] [Related]
5. Low allergenic potential with fondaparinux: results of a prospective investigation.
Schindewolf M; Scheuermann J; Kroll H; Garbaraviciene J; Hecking C; Marzi I; Wolter M; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ
Mayo Clin Proc; 2010 Oct; 85(10):913-9. PubMed ID: 20843983
[TBL] [Abstract][Full Text] [Related]
6. Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested.
Colagiovanni A; Rizzi A; Buonomo A; De Pasquale T; Pecora V; Sabato V; Aruanno A; Pascolini L; Nucera E; Schiavino D
Contact Dermatitis; 2010 Aug; 63(2):107-8. PubMed ID: 20629676
[No Abstract] [Full Text] [Related]
7. Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responses.
Schindewolf M; Recke A; Zillikens D; Lindhoff-Last E; Ludwig RJ
Contact Dermatitis; 2017 Jul; 77(1):35-41. PubMed ID: 28294347
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
[TBL] [Abstract][Full Text] [Related]
9. Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.
Tan E; Thompson G; Ekstrom C; Lucas M
Intern Med J; 2018 Jan; 48(1):73-77. PubMed ID: 29314514
[TBL] [Abstract][Full Text] [Related]
10. Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy.
Schapkaitz E; Jacobson BF
S Afr Med J; 2007 Dec; 97(12):1255-7. PubMed ID: 18271118
[No Abstract] [Full Text] [Related]
11. Intolerance of fondaparinux in a patient allergic to heparins.
Hirsch K; Ludwig RJ; Lindhoff-Last E; Kaufmann R; Boehncke WH
Contact Dermatitis; 2004 Jun; 50(6):383-4. PubMed ID: 15274739
[No Abstract] [Full Text] [Related]
12. Delayed hypersensitivity to enoxaparin.
Cabañas R; Caballero MT; López-Serrano MC; Díaz R; Contreras J; Barranco P; Moreno-Ancillo A
J Investig Allergol Clin Immunol; 1998; 8(6):383-4. PubMed ID: 10028487
[TBL] [Abstract][Full Text] [Related]
13. Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.
Koch P; Reinhold S; Busch C
Contact Dermatitis; 2000 May; 42(5):278-9. PubMed ID: 10789845
[No Abstract] [Full Text] [Related]
14. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery.
Bergqvist D
Vasc Health Risk Manag; 2006; 2(4):365-70. PubMed ID: 17323590
[TBL] [Abstract][Full Text] [Related]
15. [Prophylaxis of thromboembolic complications in bariatric surgery].
Lavrik AS; Tyvonchuk AS; Bubalo AF; Zgonnik AIu
Klin Khir; 2007 Aug; (8):39-42. PubMed ID: 18318070
[TBL] [Abstract][Full Text] [Related]
16. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
Koch P
Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
[TBL] [Abstract][Full Text] [Related]
17. [Heparins and skin reactions: from diagnostic to management].
Barouti N; Masouyé I; Boehncke WH; Prins C
Rev Med Suisse; 2013 Apr; 9(380):705-6, 708-11. PubMed ID: 23621039
[TBL] [Abstract][Full Text] [Related]
18. [Delayed intracutaneous test reaction in heparin intolerance].
Wurpts G; Merk HF
Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
[No Abstract] [Full Text] [Related]
19. Immediate type hypersensitivity after injection of nadroparin (Fraxiparin).
Bekkenk MW; van Zuuren EJ
Thromb Haemost; 2005 Sep; 94(3):673-4. PubMed ID: 16268488
[No Abstract] [Full Text] [Related]
20. Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromes.
Yan HB; Song L; Liu R; Zhao HJ; Wang SP; Chi YP; Zheng B; Li WZ; Liu C; Zhou P
Chin Med J (Engl); 2011 Mar; 124(6):879-86. PubMed ID: 21518596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
